Methane and Hydrogen Breath Test for the Diagnosis of Small Intestinal Bacterial Overgrowth

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-65
SponsorShanghai Jiao Tong University School of Medicine

About this trial

To investigate whether the positive rates of methane and hydrogen breath test were different between the experimental group and the control group.

Eligibility criteria

Qualifiers

Age 18-65 years old and gender;

Patients with functional gastrointestinal disease are characterized by abdominal symptoms (abdominal distension, early satiety, diarrhea, constipation, abdominal pain, etc.)

have the autonomy to complete methane and hydrogen breath testing and gastrointestinal symptom scoring independently or with medical assistance;

able to complete the signing of informed consent as required.

Disqualifiers

Patients whose gastroenteroscopy within one year indicated malignant tumor of digestive tract, or whose above examination proved peptic ulcer within two months;

A history of malignant tumors of the digestive system (not limited to the digestive tract), a history of inflammatory bowel disease, or a history of false or mechanical ileus;

Gastrointestinal resection, appendectomy and cholecystectomy within one year;

History of gastrointestinal perforation, gastrointestinal bleeding, cholangitis, acute and chronic pancreatitis within one year;

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed

Locations

This trial has no locations

Sponsors and collaborators

Shanghai Jiao Tong University School of Medicine

Lead sponsor

First Affiliated Hospital, Sun Yat-Sen University

Collaborator

West China Hospital

Collaborator

First Affiliated Hospital of Kunming Medical University

Collaborator

Second Affiliated Hospital, School of Medicine, Zhejiang University

Collaborator